Jinxin Fertility Group (HKG:1951) May Have Issues Allocating Its Capital
Jinxin Fertility Group (HKG:1951) May Have Issues Allocating Its Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. In light of that, when we looked at Jinxin Fertility Group (HKG:1951) and its ROCE trend, we weren't exactly thrilled.
如果你正在尋找一款多功能裝袋機,有幾件事需要注意。首先,我們想找一個正在成長的 返回 關於已用資本(ROCE),然後除此之外,還不斷增加 基礎 所用資本的比例。如果你看到這一點,這通常意味着它是一家擁有良好商業模式和大量盈利再投資機會的公司。有鑑於此,當我們查看金信生育集團(HKG: 1951)及其投資回報率趨勢時,我們並不十分興奮。
What Is Return On Capital Employed (ROCE)?
什麼是資本使用回報率(ROCE)?
Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Jinxin Fertility Group:
爲了澄清一下你是否不確定,ROCE是評估公司從投資於其業務的資本中獲得多少稅前收入(按百分比計算)的指標。分析師使用這個公式來計算金信生育集團的利潤:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
已動用資本回報率 = 息稅前收益(EBIT)÷(總資產-流動負債)
0.025 = CN¥345m ÷ (CN¥15b - CN¥1.6b) (Based on the trailing twelve months to June 2023).
0.025 = 345m cn¥3.45m ^( 150b cn¥15b-16b cn¥16b) (基於截至 2023 年 6 月的過去十二個月)。
So, Jinxin Fertility Group has an ROCE of 2.5%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 11%.
因此,金信生育集團的投資回報率爲2.5%。歸根結底,這是一個低迴報,其表現低於醫療保健行業11%的平均水平。
View our latest analysis for Jinxin Fertility Group
查看我們對金欣生育集團的最新分析
![roce](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231208/0-ed4b13e0db99a5213b9cc45b93e0347c-0-4bb963149af437eaa6d19d09dba1215d.png/big)
In the above chart we have measured Jinxin Fertility Group's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.
在上圖中,我們將金信生育集團先前的投資回報率與之前的表現進行了對比,但可以說,未來更爲重要。如果您有興趣,可以在我們關於公司分析師預測的免費報告中查看分析師的預測。
So How Is Jinxin Fertility Group's ROCE Trending?
那麼,錦欣生育集團的投資回報率趨勢如何?
On the surface, the trend of ROCE at Jinxin Fertility Group doesn't inspire confidence. Over the last five years, returns on capital have decreased to 2.5% from 7.9% five years ago. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. If these investments prove successful, this can bode very well for long term stock performance.
從表面上看,金信生育集團的投資回報率趨勢並不能激發信心。在過去五年中,資本回報率從五年前的7.9%下降到2.5%。但是,鑑於已動用資本和收入均有所增加,由於短期回報,該業務目前似乎正在追求增長。如果這些投資被證明是成功的,這對長期股票表現來說是個好兆頭。
The Bottom Line On Jinxin Fertility Group's ROCE
錦欣生育集團投資回報率的底線
While returns have fallen for Jinxin Fertility Group in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. Despite these promising trends, the stock has collapsed 75% over the last three years, so there could be other factors hurting the company's prospects. Regardless, reinvestment can pay off in the long run, so we think astute investors may want to look further into this stock.
儘管近來金信生育集團的回報率有所下降,但令我們感到鼓舞的是,銷售額正在增長,該業務正在對其業務進行再投資。儘管有這些令人鼓舞的趨勢,但該股在過去三年中仍下跌了75%,因此可能還有其他因素損害公司的前景。無論如何,從長遠來看,再投資可以獲得回報,因此我們認爲精明的投資者可能希望進一步研究這隻股票。
If you'd like to know about the risks facing Jinxin Fertility Group, we've discovered 3 warning signs that you should be aware of.
如果您想了解金信生育集團面臨的風險,我們發現了您應該注意的3個警告信號。
While Jinxin Fertility Group isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
儘管金信生育集團的回報率不是最高的,但請查看這份免費清單,列出了資產負債表穩健且股本回報率高的公司。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。